0 Table of Contents |
1 Overview |
2 Adverse Event Algorithms |
3 Profile Descriptions |
4 Relationship to US-Core |
5 ICSR Mappings |
6 Pull Use Case |
7 Artifacts Summary |
7.1 ICSR Adverse Event |
7.2 AECountObservation |
7.3 Descriptive Age Group for the Patient |
7.4 ExposureCountObservation |
7.5 ICSR Blood Product |
7.6 ICSR Bundle |
7.7 ICSR Composition |
7.8 ICSR Convalescent Plasma |
7.9 ICSR Immunization |
7.10 ICSR MedicationAdministration |
7.11 ICSR MessageHeader |
7.12 ICSR Patient |
7.13 ICSR Transfusion |
7.14 MessageHeader Organization |
7.15 Patient Body Height in cm |
7.16 Patient Body Weight in kg |
7.17 Patient's Date of Last Menstrual Period |
7.18 Practitioner Author |
7.19 PractitionerRole Author |
7.20 RelatedPerson Author |
7.21 Transfusion Adverse Event |
7.22 Vaccination Adverse Event |
7.23 AdditionalDocumentInformation |
7.24 AgeAtTimeOfOnset |
7.25 AgeAtVaccination |
7.26 AuthorPrimarySource |
7.27 CaseIdentifier |
7.28 CombinationProductReport |
7.29 DepartmentName |
7.30 DonationIdentificationNumber |
7.31 EventDuration |
7.32 EventEndDate |
7.33 EventSeriousness |
7.34 ExpeditedReport |
7.35 FirstReceiveDate |
7.36 FirstSenderType |
7.37 MilitaryStatus |
7.38 MostRecentDate |
7.39 PreviousCaseIdentifier |
7.40 ReportAmendment |
7.41 UsedProduct |
7.42 UsedProductAmount |
7.43 Codes that represent a transfusion procedure Value Set |
7.44 COVID-19 Vaccine Codes |
7.45 ICSR Section Codes Value Set |
7.46 ICSR Seriousness Codes |
7.47 ICSR Top-Level Seriousness |
7.48 Influenza Vaccine Codes |
7.49 ISBT Blood Product Codes |
7.50 ISBT Convalescent Plasma Codes |
7.51 Patient Age Group |
7.52 Patient Military Status |
7.53 Transfusion-related Adverse Events |
7.54 Vaccination-related Adverse Events |
7.55 Vaccine Codes |
7.56 ICSR Data Source Observation Codes Code System |
7.57 ICSR Section Codes Code System |
7.58 BEST Author of ICSR Reports |
7.59 BEST Author Role of ICSR reports |
7.60 BEST Patient Age Group |
7.61 BEST Patient for Transfusion Sample |
7.62 Minimum Transfusion Case Report Bundle |
7.63 Minimum Vaccination Case Report Bundle |
7.64 Receiver Organization for FAERS |
7.65 Sample Adverse Event Count Observation |
7.66 Sample Author Role of ICSR Report |
7.67 Sample Blood Product |
7.68 Sample Convalescent Plasma |
7.69 Sample Exposure Count Observation |
7.70 Sample ICSR Report Patient |
7.71 Sample ICSR Transfusion Report |
7.72 Sample ICSR Vaccination Report |
7.73 Sample MessageHeader for Transfusion |
7.74 Sample MessageHeader for Transfusion report for Connecathon |
7.75 Sample MessageHeader for Vaccination |
7.76 Sample MessageHeader for Vaccination report for Connecathon |
7.77 Sample Patient Height Observation |
7.78 Sample Patient Menstrual Period Date Observation |
7.79 Sample Patient Weight Observation |
7.80 Sample Practitioner Author of ICSR Report |
7.81 Sample Related Person Author of ICSR Report |
7.82 Sample Sender Organization |
7.83 Transfusion BEST Prototype |
7.84 Transfusion Bundle for Connectathon Sample |
7.85 Transfusion Diphenhydramine Administration |
7.86 Transfusion Epinephrine Administration |
7.87 Transfusion FDA Organization |
7.88 Transfusion Sample Event |
7.89 Transfusion Sample ICSR Report |
7.90 Transfusion Suspect Transfusion |
7.91 Vaccination Author of ICSR Reports |
7.92 Vaccination Author Role of ICSR reports |
7.93 Vaccination Bundle for Connectathon Sample |
7.94 Vaccination Hydrocortisone Administration |
7.95 Vaccination Patient for Transfusion Sample |
7.96 Vaccination Sample Event |
7.97 Vaccination Sample ICSR Report |
7.98 Vaccination Sample Immunization for Connectathon Sample |
7.99 Vaccination Sending Organization |